US-listed company Sonnet BioTherapeutics postpones merger vote to December 2
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Foresight News reported that the US-listed company Sonnet BioTherapeutics has postponed its merger vote to December 2. Previously, it was reported that Sonnet BioTherapeutics would merge with Rorschach I LLC to form Hyperliquid Strategies and advance the HYPE reserve strategy.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Crypto prices
MoreBitcoin
BTC
$73,343.8
-0.46%
Ethereum
ETH
$2,041.61
-0.58%
Tether USDt
USDT
$0.9988
-0.00%
BNB
BNB
$670.67
-1.23%
USDC
USDC
$0.9998
+0.01%
XRP
XRP
$1.05
-0.44%
Solana
SOL
$83.08
-0.38%
TRON
TRX
$0.3163
-0.35%
Hyperliquid
HYPE
$71.46
-0.87%
Zcash
ZEC
$978.97
-0.16%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now


